Literature DB >> 20126827

Long- and short-term in vitro D-dimer stability measured with INNOVANCE D-Dimer.

M Böhm-Weigert1, T Wissel, H Muth, B Kemkes-Matthes, D Peetz.   

Abstract

In vitro D-dimer stability in plasma is widely assumed, but has not yet been documented by systematic studies using samples covering a wide range of D-dimer. We investigated the short- and long-term stability of D-dimer in clinical citrated plasma samples with normal and pathological levels. The short-term stability was analysed by measuring D-dimer fresh, after storage of plasma for 4 hours at room temperature (RT) and after an additional 24 h storage at +2 to +8 degrees C (n=40). Long-term stability samples (n=40) were measured fresh and after storage for 19, 25 and 36 months at < or =-60 degrees C. The effect of repeated freezing was analysed by measuring samples (n=50) fresh and after four consecutive freeze-thaw cycles. D-dimer was measured on the BCS System using the INNOVANCE D-Dimer assay (Siemens Healthcare Diagnostics Products GmbH, Marburg, Germany). D-dimer values at baseline ranged from 0.23-22.2 mg/l FEU. The mean percentage change after storage for 4 hours at RT and additional 24 hours at +2 to +8 degrees C was +3.8% and +2.7%, respectively. The mean percentage change after frozen storage for 19, 25 and 36 months at < or =-60 degrees C was -11.7%, -4.8% and -9.3%, respectively. The small decrease of D-dimer values after frozen storage was not time-dependent. Repeated freezing did not significantly alter D-dimer values (mean change < or =5%). The data demonstrate stability of D-dimer in plasma prior to freezing for up to 4 hours at RT and for up to 24 hours at +2 to +8 degrees C as well as in plasma stored for up to three years at < or =-60 degrees C.

Mesh:

Substances:

Year:  2009        PMID: 20126827     DOI: 10.1160/TH09-04-0230

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  2 in total

1.  D-dimer corrected for thrombin and plasmin generation is a strong predictor of mortality in patients with sepsis.

Authors:  Fabrizio Semeraro; Concetta T Ammollo; Pietro Caironi; Serge Masson; Roberto Latini; Mauro Panigada; Antonio Pesenti; Nicola Semeraro; Luciano Gattinoni; Mario Colucci
Journal:  Blood Transfus       Date:  2019-11-19       Impact factor: 3.443

2.  Investigation of the Molecular Mechanism of Coagulopathy in Severe and Critical Patients With COVID-19.

Authors:  Daniel Elieh Ali Komi; Yaghoub Rahimi; Rahim Asghari; Reza Jafari; Javad Rasouli; Mehdi Mohebalizadeh; Ata Abbasi; Rahim Nejadrahim; Farzin Rezazadeh; Vahid Shafiei-Irannejad
Journal:  Front Immunol       Date:  2021-12-16       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.